HONLIV HEALTH (09906) announced that on December 11, 2024, Teng Qingxiao resigned as the company's Executive Director, effective the same day, to devote more time to focus on the company's Operation and management. Dr. Teng will remain as the company's Chief Operating Officer and Senior Vice President.
Li Yanhong has been appointed as Executive Director, effective from December 11, 2024.